跳至主要内容
临床试验/NCT00330798
NCT00330798已完成4 期

A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status Post-Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study

Alcon Research1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2006年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Subjective pain

研究概览

简要总结

The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 19 years or older with healthy ocular status and pre-operative refractive anisometropia of less than 2.000 diopters between eyes undergoing bilateral PRK surgery.
  • Other protocol-defined inclusion criteria may apply.

排除标准

  • Those desiring PRK in only one eye, those in need of additional topical eye medications, those with history of drug/alcohol abuse, women breastfeeding or pregnant.
  • Other protocol-defined exclusion criteria may apply.

研究组 & 干预措施

Nevanac

Experimental

One drop, three times daily, in the assigned eye for the first three postoperative days

干预措施: nepafenac 0.1% (Drug)

Acular LS

Placebo Comparator

One drop, three times daily, in the assigned eye for the first three postoperative days

干预措施: ketorolac 0.4% (Other)

结局指标

主要结局

Subjective pain

时间窗: Day 5

次要结局

  • Rate of epithelial healing(Time to event)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Comparison of Topical Nepafenac to Placebo in... | 临床试验